The cost effectiveness of lung transplantation compared with that of heart and liver transplantation in the Netherlands

JP Ouwens*, PJ van Enckevort, EM TenVergert, GJ Bonsel, W van der Bij, EB Haagsma, FFH Rutten, MJH Slooff, GH Koeter

*Corresponding author for this work

Research output: Contribution to journalArticleAcademicpeer-review

33 Citations (Scopus)

Abstract

This study was performed to assess the main reasons for the unfavorable cost effectiveness of lung transplantation compared with that of heart and liver transplantation. Costs, effects, and cost-effectiveness ratios of Dutch lung, heart, and liver transplantation programs were compared. The data are based on three Dutch technology assessments of transplantation, with minor adjustments for time and methods. In result, mainly follow-up costs of lung transplantation are higher than costs of heart and liver transplantation - US $150,300, US $121,500, and US $95,300, respectively - in the first 3 years after transplantation. The survival gain realized by lung transplantation is small (4.4 years) compared with heart (8.8 years) and liver (14.7years) transplantation. Costs per life-year gained were US $77,000, US $38,000, and US $26,000 for lung, heart, and liver transplantation, respectively. The unfavorable cost effectiveness of lung transplantation is largely related to a relatively small survival gain and high follow-up costs.

Original languageEnglish
Pages (from-to)123-127
Number of pages5
JournalTransplant International
Volume16
Issue number2
DOIs
Publication statusPublished - Feb-2003

Keywords

  • cost-benefit analysis
  • lung transplantation
  • liver transplantation
  • heart transplantation
  • PROGRAM
  • LIFE

Cite this